After effectively capturing domestic markets, Bangalore based medical devices company, Forus Health Pvt. Ltd has taken its accurate and affordable eye screening device, the 3nethra classic, to international shores. Earlier this year, Forus Health had got the 3nethra classic device FDA registered in the US and officially launched the non-mydriatic camera into the US market at the recently concluded American Academy of Ophthalmology meeting in Chicago where it got a resounding response from Ophthalmologists present.
Since its inception, Forus Health has sold over 1,200 classic fundus cameras in 26 countries around the globe and this further solidifies the company’s aim to eradicate preventable blindness throughout the world.
3nethra is a technology innovation which helps in screening of common eye problems which can lead to blindness. It is simple, portable, rugged and can be operated by a minimally trained technician. Ophthalmologists in attendance were pleased to discover the results of crisp fundus images, the simplicity in its’ use and the financial advantages that the Classic provides as a primary office camera or as a screening camera for satellite offices.
The United States of America is the largest medical devices market in the world and has approximately 35000 practicing ophthalmologists resulting in massive potential of doing business. Forus Health is committed to optimizing their presence in US and is building a strong team of high-value individuals to lead operations. Dr. Cliff Wright has assumed the role of Executive Vice President for North America and heads operations out of Forus Health’s newly opened bay area office in San Leandro, CA. He has 20 years of Optometric clinical experience and 15 years of senior business leadership experience in global health and eye care brands. Armond Dantino has been appointed Senior Sales Director (North America) and is based out of Florida. He brings 15 years of Executive Sales Management and is a true business leader with US and International success in defining and executing strategies that strengthen revenue, profit, and market share in highly competitive startup, turnaround, and expansion environments
Commenting on the occasion, K Chandrashekhar, CEO, Forus Health said “Preventable Blindness is a global problem and this move has brought us a step closer to addressing it worldwide. We at Forus believe not just in technological innovation but its effective deployment as well and our presence in a developed market like the US will strengthen our position and ability to reach more people across the globe.’
Since its inception, Forus Health has sold over 1,200 classic fundus cameras in 26 countries around the globe and this further solidifies the company’s aim to eradicate preventable blindness throughout the world.
3nethra is a technology innovation which helps in screening of common eye problems which can lead to blindness. It is simple, portable, rugged and can be operated by a minimally trained technician. Ophthalmologists in attendance were pleased to discover the results of crisp fundus images, the simplicity in its’ use and the financial advantages that the Classic provides as a primary office camera or as a screening camera for satellite offices.
The United States of America is the largest medical devices market in the world and has approximately 35000 practicing ophthalmologists resulting in massive potential of doing business. Forus Health is committed to optimizing their presence in US and is building a strong team of high-value individuals to lead operations. Dr. Cliff Wright has assumed the role of Executive Vice President for North America and heads operations out of Forus Health’s newly opened bay area office in San Leandro, CA. He has 20 years of Optometric clinical experience and 15 years of senior business leadership experience in global health and eye care brands. Armond Dantino has been appointed Senior Sales Director (North America) and is based out of Florida. He brings 15 years of Executive Sales Management and is a true business leader with US and International success in defining and executing strategies that strengthen revenue, profit, and market share in highly competitive startup, turnaround, and expansion environments
Commenting on the occasion, K Chandrashekhar, CEO, Forus Health said “Preventable Blindness is a global problem and this move has brought us a step closer to addressing it worldwide. We at Forus believe not just in technological innovation but its effective deployment as well and our presence in a developed market like the US will strengthen our position and ability to reach more people across the globe.’
Advertisements